You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

POTASSIUM CHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Potassium Chloride patents expire, and when can generic versions of Potassium Chloride launch?

Potassium Chloride is a drug marketed by Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Chartwell Molecular, Glenmark Pharms Ltd, Granules, Lupin Ltd, Nesher Pharms, Novel Labs Inc, Padagis Us, Ph Health, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Ajenat Pharms, Amneal, Anda Repository, Epic Pharma Llc, Genus, Novitium Pharma, Rubicon Research, Abraxis Pharm, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Nexus, Pharma Serve Ny, Watson Labs, Apotex, Ascent Pharms Inc, Aurobindo Pharma, Genus Lifesciences, Macleods Pharms Ltd, Pharm Assoc, Quagen, Sciegen Pharms, Taro, Wes Pharma Inc, Aurobindo Pharma Ltd, Breckenridge, Chartwell Rx, Copley Pharm, Guangzhou Novaken, Pharmobedient, Rising, Schering, Sigmapharm Labs Llc, Twi Pharms, Yichang Humanwell, Otsuka Icu Medcl, and Icu Medical Inc. and is included in one hundred and thirty-seven NDAs. There is one patent protecting this drug.

The generic ingredient in POTASSIUM CHLORIDE is calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate. There are two hundred and eighty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate profile page.

DrugPatentWatch® Generic Entry Outlook for Potassium Chloride

Annual sales in 2022 were $9mm indicating the motivation for generic entry (peak sales were $386mm in 2004).

Indicators of Generic Entry

< Available with Subscription >

  Get Started Free

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for POTASSIUM CHLORIDE?
  • What are the global sales for POTASSIUM CHLORIDE?
  • What is Average Wholesale Price for POTASSIUM CHLORIDE?
Summary for POTASSIUM CHLORIDE
US Patents:1
Applicants:59
NDAs:137

US Patents and Regulatory Information for POTASSIUM CHLORIDE

POTASSIUM CHLORIDE is protected by one US patents.

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare POTASSIUM CHLORIDE 5MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018008-004 Approved Prior to Jan 1, 1982 RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Luitpold POTASSIUM CHLORIDE potassium chloride INJECTABLE;INJECTION 087585-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Otsuka Icu Medcl POTASSIUM CHLORIDE 10MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161-005 Nov 30, 1992 AP RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
B Braun POTASSIUM CHLORIDE 0.15% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 019630-028 Feb 17, 1988 AP RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Macleods Pharms Ltd POTASSIUM CHLORIDE potassium chloride SOLUTION;ORAL 218733-002 Sep 10, 2025 AA RX No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for POTASSIUM CHLORIDE

See the table below for patents covering POTASSIUM CHLORIDE around the world.

Country Patent Number Title Estimated Expiration
Hong Kong 16093 CONTROLLED RELEASE POTASSIUM CHLORIDE ⤷  Get Started Free
Norway 172375 ⤷  Get Started Free
Spain 552145 ⤷  Get Started Free
Finland 864207 ⤷  Get Started Free
Canada 1270765 CHLORURE DE POTASSIUM A LIBERATION CONTROLEE (CONTROLLED RELEASE POTASSIUM CHLORIDE) ⤷  Get Started Free
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for POTASSIUM CHLORIDE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
3141251 301099 Netherlands ⤷  Get Started Free PRODUCT NAME: A MEDICINAL PRODUCT CONSISTING OF A COMBINATION OF A FIRST DOSE PHARMACEUTICAL COMPOSITION AND A SECOND DOSE PHARMACEUTICAL COMPOSITION, THE FIRST DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS POLYETHYLENE GLYCOL, SODIUM SULPHATE, SODIUM CHLORIDE AND POTASSIUM CHLORIDE AND THE SECOND DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS POLYETHYLENE GLYCOL, ASCORBIC ACID, SODIUM ASCORBATE, SODIUM CHLORIDE AND POTASSIUM CHLORIDE; NATIONAL REGISTRATION NO/DATE: RVG 120195 20171114; FIRST REGISTRATION: IS IS/1/17/083/01 20171016
1441735 SPC/GB08/020 United Kingdom ⤷  Get Started Free PRODUCT NAME: RALTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; REGISTERED: UK EU/1/07/436/001 20080102
1718641 2012/008 Ireland ⤷  Get Started Free PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTRATION NO/DATE: EU/1/11/734/001-011 EU/1/11/735/001-011 20111209
1441735 08C0026 France ⤷  Get Started Free PRODUCT NAME: RALTEGRAVIR POTASSIUM; REGISTRATION NO/DATE: EU/1/07/436/001 20080102
1499331 13C0055 France ⤷  Get Started Free PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Investment Analysis, Market Dynamics, and Financial Trajectory for Potassium Chloride

Last updated: February 3, 2026


Executive Summary

Potassium chloride (KCl) is a key electrolyte supplement extensively used in medical, agricultural, and industrial applications. The global market for potassium chloride is projected to grow at a compound annual growth rate (CAGR) of approximately 4.2% from 2023 to 2030, driven primarily by expanding medical applications, increasing agricultural demand, and industrial usage. Investment opportunities, however, are influenced by supply chain fluctuations, regulatory environments, and geopolitical factors. This report offers an in-depth analysis of market dynamics, revenue projections, and strategic considerations for stakeholders evaluating investments in potassium chloride.


What Are the Fundamental Drivers of Market Growth for Potassium Chloride?

Market Demand Drivers

Driver Details Impact \
Medical applications Used in IV therapy and electrolyte replenishment High growth driven by aging populations and increasing healthcare expenditure
Agricultural sector Main source of potash fertilizer Elevated demand due to global food security initiatives and fertilizer consumption growth
Industrial uses Includes chemical manufacturing and de-icing Growing industrialization in emerging economies

Supply Chain and Production Factors

Factor Description Effect on Market
Major producers Canada, Russia, Belarus, Chile Geopolitical tensions can affect supply stability
Mining capacity Crude potash mining expansion efforts Potential for increased supply or bottlenecks
Regulatory changes Environmental policies May hinder or facilitate production expansion

Regulatory Environment

Aspect Description Market Impact
Environmental standards stricter mining and environmental controls Increased compliance costs but potential for sustainable growth
Import/export policies Trade tariffs and sanctions Market access and price fluctuations

Market Size, Revenue Trends, and Financial Trajectory

Current Market Size

Parameter 2022 Data Estimated 2023 Notes
Global potassium chloride market ~$19.5 billion ~$20.3 billion Approximate, based on industry reports by Research and Markets [1]
CAGR (2023–2030) 4.2% Projected growth rate

Segmental Breakdown

Segment Revenue Share (2022) CAGR (2023–2030) Key Factors
Agriculture 65% 4.5% Fertilizer demand, crop yields
Medical 20% 3.8% Increased healthcare spending
Industrial 15% 3.9% Chemical manufacturing, de-icing

Regional Market Analysis

Region 2022 Revenue Growth Drivers Challenges
Asia-Pacific ~$9.8B Agricultural expansion, industrialization Environmental regulations
North America ~$4.3B Healthcare demand, fertilizer use Regulatory scrutiny
Europe ~$3.2B Sustainable farming policies Import dependency

Financial Projections (2023–2030)

Year Revenue (Billion USD) Assumed CAGR Notes
2023 20.3 Baseline
2025 22.5 4.2% Mid-term growth
2030 27.7 4.2% Long-term projections

Revenue Drivers

  • Fertilizer demand: Anticipated to account for approximately 70% of growth.
  • Medical sector: Projected 3.8% CAGR driven by chronic disease management and aging demographics.
  • Industrial use: Steady expansion due to infrastructure development.

Market Dynamics and Investment Considerations

Supply and Demand Risks

Risk Description Mitigation Strategy
Geopolitical tensions Russia and Belarus account for over 40% of global production [2] Diversify supply sources, enhance inventory buffers
Environmental restrictions Stricter standards may limit mining output Invest in sustainable extraction technologies
Price volatility Commodity price swings affect profit margins Hedge strategies, long-term supply contracts

Pricing Trends and Margins

Parameter 2022 2023 Projection Notes
Average spot price per ton ~$350 Slight increase Volatility influenced by supply disruptions
Profit margins 15–20% Expected to stabilize Industry consolidation may impact margins

Competitive Landscape

Company Market Share (2022) Key Strengths Strategic Moves
Nutrien Ltd. 25% Integrated supply chain Capacity expansion plans
OCP Group 15% Focus on sustainable mining R&D in eco-friendly extraction
Yara International 10% Broad distribution network Diversification into specialty fertilizers

Regulatory and Policy Impacts

Policy Area Implication Strategic Response
International trade agreements Impact on export tariffs Establish local partnerships
Environmental policies Higher compliance costs Invest in cleaner technology

Comparison with Alternative Fertilizer and Electrolyte Solutions

Aspect Potassium Chloride Alternatives Remarks
Cost competitiveness Moderate Lower (e.g., potassium sulfate) Price-sensitive segments
Supply stability Moderate Varies by region Infrastructure impacts
Application versatility High N/A Widely accepted for crops and medical use

Investment Outlook and Strategic Recommendations

Aspect Guidance
Entry points Favor early-stage expansion projects or companies with diversified markets
Risk management Hedge against geopolitical and supply chain risks with diversified sourcing and inventory buffers
Growth opportunities Focus on emerging markets with high agricultural expansion and healthcare growth
Technological innovation Support R&D in sustainable mining and environmentally friendly production methods
Policy environment Monitor regulatory changes to adapt swiftly and capitalize on compliance incentives

Deep Dive: Market Comparison and Deep Analysis

Parameter Potassium Chloride Sodium Chloride Calcium Carbonate
Core application Fertilizer, medical, chemical Food additive, de-icing Construction, industrial filler
Market CAGR (2023–2030) 4.2% 2.5% 3.1%
Key drivers Agriculture expansion, healthcare Food processing, supply chain stability Construction activities
Price volatility Moderate Low Moderate

Note: The higher CAGR for KCl reflects its role in global food security initiatives and healthcare demand, which outpaces some industrial standards.


FAQs

1. What are the main growth drivers for potassium chloride’s market valuation?
Key drivers include increasing fertilizer demand due to global agricultural expansion, rising healthcare expenditure for electrolyte therapies, especially among aging populations, and industrial applications like de-icing and chemical manufacturing.

2. How do geopolitical factors influence the potassium chloride supply chain?
Major producers such as Russia and Belarus account for roughly 40% of global output. Sanctions, trade tensions, or conflicts can restrict supply, impacting prices and market stability.

3. What investment risks are associated with potassium chloride markets?
Primary risks include supply disruptions from geopolitical tensions, environmental regulations increasing operational costs, price volatility in raw material markets, and shifts toward alternative fertilization or medical solutions.

4. How sustainable are current production methods for potassium chloride?
While traditional mining methods face environmental scrutiny, companies are investing in sustainable practices, including eco-friendly extraction techniques and recycling, to meet stricter standards and reduce ecological impacts.

5. What are the strategic advantages for investors in potassium chloride?
Investors benefit from diversified applications, consistent demand in essential sectors, and the potential for growth in emerging markets. Innovations in sustainable extraction and supply chain resilience further enhance strategic positioning.


Key Takeaways

  • Potassium chloride exhibits a robust growth outlook (~4.2% CAGR), underpinned by agriculture, healthcare, and industrial demand.
  • Major supply is concentrated among a few geopolitical regions, posing risks that can be mitigated through diversification and strategic inventory management.
  • The global market faces moderate volatility; pricing is influenced by supply disruptions and geopolitical tensions.
  • Investment opportunities lie in companies with strong supply chain resilience, sustainable extraction practices, and diversified market reach.
  • Regulatory and environmental policies will increasingly shape production strategies and market stability.

References:
[1] Research and Markets, “Global Potassium Chloride Market Report,” 2022.
[2] USGS Mineral Commodity Summaries, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.